Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%

Buprenorphine vs methadone

Mean days in treatment · Adults with opioid dependence

1 finding from 1 review

Buprenorphine for managing opioid withdrawal 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 82 participants
Low

Buprenorphine vs alpha2‐adrenergic agonists

Mean days in treatment (with varying scheduled duration) · Adults or adolescents with opioid dependence

Buprenorphine probably leads to higher mean days in treatment (with varying scheduled duration) compared with alpha2‐adrenergic agonists (moderate certainty).

1 finding from 1 review

Buprenorphine for managing opioid withdrawal 2017 · Cochrane Headline outcomes only
SMD 0.92 [0.57, 1.27]
4 studies · 558 participants
Moderate